How can genetic testing help me decide if tirzepatide is right for me
There is some rebound coming off the drugs anyway, but you risk rebounding where you basically go back to where you were without long-lasting behavioral change. The GLP-1 receptor agonistsas well as tirzepatide (Zepbound
Just like GLP-1 medications, these help with physical fullness and slower digestion in a more mild way
Your provider can help manage symptoms and monitor your response
Back to Journals Diabetes, Metabolic Syndrome and Obesity Volume 19 Gastrointestinal Adverse Effects of GLP-1 and Dual GLP-1/GIP Receptor Agonists: A Comprehensive Update in Diabetic and Obese Populations Authors Ylmaz N , Bastemir M Received 27 November 2025 Accepted for publication 13 January 2026 Published 30 January 2026 Volume 2026:19 584175 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 4 Editor who approved publication: Dr Halis Akturk Nimet Ylmaz, 1 Mehmet Bastemir 2 1 Department of Gastroenterology, SANKO University Faculty of Medicine, Gaziantep, Turkey
Fixed-dose combinations improve medication compliance: a meta-analysis